Quantcast
Channel: WN.com - Articles related to Preclinical Data of Xencor's XmAb Bispecific Technology to be Presented at Upcoming ASH Annual Meeting
Viewing all articles
Browse latest Browse all 614

Xencor's (XNCR) CEO Bassil Dahiyat on Q3 2016 Results - Earnings Call Transcript

$
0
0
Xencor, Inc. (NASDAQ:XNCR) Q3 2016 Earnings Conference Call November 02, 2016 4:30 PM ET Executives Hannah Deresiewicz - Stern Investor Relations Bassil Dahiyat – President, Chief Executive Officer and Director John Kuch - Vice President, Finance Analysts Jonathan Chang - Leerink Partners Ted Tenthoff - Piper Jaffray David Nierengarten - Wedbush Securities Arlinda Lee - Canaccord Genuity Operator Good day, ladies and gentlemen, and welcome to the Xencor Incorporated Q3 2016 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will have a question-and-answer session and instructions will be given at that time. [Operator Instructions] I would now like...

Viewing all articles
Browse latest Browse all 614

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>